| For: | Phiri P, Engelthaler T, Carr H, Delanerolle G, Holmes C, Rathod S. Associated mortality risk of atypical antipsychotic medication in individuals with dementia. World J Psychiatry 2022; 12(2): 298-307 [PMID: 35317344 DOI: 10.5498/wjp.v12.i2.298] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v12/i2/298.htm |
| Number | Citing Articles |
| 1 |
Isa Brito Félix, Margarida Fernandes, Jeffery David Hughes, Kreshnik Hoti, Mara Pereira Guerreiro. Towards person-centered pain management in dementia: usability of a digital medical device in Portuguese residential care facilities. Frontiers in Health Services 2026; 6 doi: 10.3389/frhs.2026.1829082
|
| 2 |
Arezo Shakeri, Mina Farmanbar. Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2025; 17(1) doi: 10.1002/dad2.70082
|
| 3 |
Carlo Rossi, Nicole Campese, Carlo Colosimo. Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review. Expert Opinion on Pharmacotherapy 2023; 24(13) doi: 10.1080/14656566.2023.2224501
|
| 4 |
Isa Brito Félix, Catarina Ramos, Rui Guerreiro, Jeffery David Hughes, Kreshnik Hoti, Teresa Andrade, Mara Guerreiro. Barriers and strategies for pain management in non-verbal people with dementia in residential care facilities: protocol for an e-Delphi study. BMJ Open 2025; 15(11) doi: 10.1136/bmjopen-2025-107077
|
| 5 |
Mara Pereira Guerreiro, Isa Brito Félix, Morgane Tomé, Kreshnik Hoti, Catarina Ramos, Beatriz Dias, Teresa Andrade, José Brito, Jeff Hughes. Protocol for a usability and pilot implementation study of a digital medical device to assess pain in non-verbal people with dementia in Portuguese residential care facilities. DIGITAL HEALTH 2025; 11 doi: 10.1177/20552076241311326
|
| 6 |
Lorenza Pabst Botton, Fernando Jacob Lazzaretti, Carlos Lokschin, Tharick A. Pascoal, Jaderson Costa da Costa, Bruce L. Miller, Lucas P. Schilling, Cristiano S. Aguzzoli. Pharmacological management in frontotemporal dementia and patient outcomes: a retrospective cohort study using the TriNetX platform. Frontiers in Neurology 2026; 17 doi: 10.3389/fneur.2026.1930046
|
| 7 |
Harsharon Kaur Sondh, Christoph Mueller, Delia Bishara, Robert Stewart. The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disorders. Expert Review of Clinical Pharmacology 2025; 18(10) doi: 10.1080/17512433.2025.2576102
|
| 8 |
Shanquan Chen, Rudolf N. Cardinal, Kathryn Auckland, Stefan Gräf, John T. O’Brien, Benjamin R. Underwood. Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study. Journal of Alzheimer's Disease 2023; 92(1) doi: 10.3233/JAD-221093
|
| 9 |
Duncan McLauchlan, Cheney Drew, Peter Holmans, Anne Rosser. Exploring the association between antidepressants, progression and mortality in Huntington’s disease. Brain 2026; 149(8) doi: 10.1093/brain/awag009
|
| 10 |
亭 朱. Progress in the Treatment of Alzheimer’s Disease. Advances in Clinical Medicine 2023; 13(03) doi: 10.12677/ACM.2023.133433
|
| 11 |
Poe Eindra Thant, Alina Zenker, Johan Jarl, Ulf-Göran Gerdtham, Cecilia Lenander, Sofie Persson, Sanjib Saha. The consequences of antipsychotic medication use for people living with dementia: a systematic review and meta-analysis. Frontiers in Psychiatry 2026; 17 doi: 10.3389/fpsyt.2026.1817609
|
| 12 |
Ana Todorovic, Philip Craig, Simon Pillinger, Panagiota Kontari, Sophie Gibbons, Luke Bryden, Tarso Franarin, Ceyda Uysal, Gloria Roque, Benjamin Fell. Akrivia Health Database—deep patient characterisation using a secondary mental healthcare dataset in England and Wales: cohort profile. BMJ Open 2024; 14(10) doi: 10.1136/bmjopen-2024-088166
|
| 13 |
Zhi-Peng Li, Yu-Shun You, Jun-Dong Wang, Lian-Ping He. Underlying disease may increase mortality risk in users of atypical antipsychotics. World Journal of Psychiatry 2022; 12(8): 1112-1114 doi: 10.5498/wjp.v12.i8.1112
|